Background: The use of mineral (clay) or biologic (chitosan) materials has improved the efficacy of dressings used in the bleeding control of noncompressible areas. A series of novel manufactured products already evaluated in a vascular transection model was further compared in a severe vascular puncture injury model. Methods: Ten hemostatic dressings were tested in anesthetized Yorkshire swine hemorrhaged for 45 seconds in a femoral arterial puncture model. Application of these dressings was followed by 5 minutes of compression (about 175 mm Hg), and at 15 minutes, 500 mL resuscitation fluid (Hextand) was infused during a 30-minute period. The animals were monitored for a 3-hour experimental observation period. Primary outcomes were incidence of bleeding after dressing application and animal survival. Results: Blood loss was 18.8% ؎ 5.2% estimated blood volume (EBV) after 45 seconds of free bleeding. Relative performance of dressings is characterized as groups of dressings that performed similarly. Recurrence of bleeding after application was observed with most dressings and was lower with Woundstat, Celox, X-Sponge, and ACS؉ (35% ؎ 49%) compared with FP-21, Hemcon, Chitoflex, and Bloodstop (79% ؎ 43%; P < .01). Blood loss after treatment was 25.3% ؎ 18.4% EBV for the top four dressings and 53.0% ؎ 18.4% EBV for the bottom four (P < .05). Survival was higher for top four vs bottom four dressings (78% ؎ 12% vs 25% ؎ 0%, respectively; P < .01). Overall performance of these dressings according to survival, incidence of bleeding, and post-treatment blood loss, yielded similar ranking as with a previously tested transection injury model. 
Methods to suppress massive external hemorrhage should be provided immediately after injury and should control active bleeding within minutes to prevent death or consequences of hypovolemia and hypoperfusion. [1] [2] [3] The amount of blood lost relates to the type of injury and dictates survival. Compression points remain a very effective method to stop bleeding in extremities. [4] [5] [6] In most noncompressible cases, standard of care treatment of a slow hemorrhage involves using cellulose-based compressed gauze (eg, Kerlix dressings) as the first action to absorb blood. 7 The use of these simple dressings assumes that hemostasis will eventually be restored naturally by clot formation, vessel constriction, or retraction, but subsequent bleeding (rebleeding) may occur and require additional dressing applications.
As an alternative to bleeding control, tourniquets, used efficiently for extremities, are not suited for noncompressible areas such as the neck, peritoneum, or groin. Promising solutions for controlling rapid bleeding in these areas could come from novel hemostatic dressings with maximum efficacy in a single application. 4, 8 By adding an active hemostatic agent to a supportive matrix, the first generation of improved dressings has contributed to better bleeding control in noncompressible areas. [9] [10] [11] [12] [13] [14] [15] [16] The selection of dressings for military conflict-related situations, including non- compressible wounds, requires identification of specific products that exhibit superior performance in these challenging injuries.
Recently, major developments have been made in the composition, texture, and active constituent materials of hemostatic dressings. 11, [17] [18] [19] [20] The relative efficacy of these dressings may be influenced by their form, nature, and application, especially in trauma patients with bleeding wounds. These improved hemostatic dressings were evaluated in an animal vascular transection injury model and showed better performance than standard compressed gauze, but the difference between dressings was minimal. 19 Owing to different modes of action and presentation of these diverse products, it is reasonable to assume that effectiveness will vary with the severity of injury. For example, some hemostatic dressings may perform better in highpressure bleeding injuries, whereas others may be more effective in slower bleeding injuries. Therefore, efficacy of these dressings needs to be confirmed for bleeding control and long-term secure placement on the wound (when the casualty is moved through difficult terrains and situations or experiences a long delay for evacuation) in other types of severe injury models.
Even though in the transection model the rupture of vessels and muscles is designed to represent multiple injuries associated with combat injury, 21 application of bandages may not be sufficiently challenged by active bleeding in this model. In a continuous effort to find the best performing dressings, we evaluated products in a severe vascular puncture injury model with a high initial bleeding rate and low survival. 20, 22 The objective of this study is to compare the efficacy of hemostatic dressings of different nature (eg, granular, fabricbased) with standard gauze. The specific hypotheses of this project are that the new products are more efficacious than standard gauze in (1) arresting bleeding, (2) preventing additional bleeding over time, and (3) improving survival. Further, they should have comparable or better efficacy than Zeolite and ACSϩ hemostatic dressings currently approved for use in United States (U.S.) military.
MATERIALS AND METHODS
Hemostatic dressings. The products used for this study and their abbreviations referred to throughout are listed in Table I . The hemostatic products and the standard compressed gauze bandage (SD; H&H compressed gauze, H&H Associates, Bena, Va) were categorized according to nature, form, and composition. Hemostatic dressings were made of a wide range of material from mineral-based products made of zeolite, smectite, and kaolin to biologically based products made of chitin. We tested 10 different hemostatic agents and one control SD (11 groups in total). A more detailed description of each of the products was reported by Arnaud et al in 2009. 19 Animal model. The study adhered to the principles in the Guide for the Care and Use of Laboratory Animals, (National Research Council, 1996 Edition). The study was approved by the Naval Medical Research Center/Walter Reed Army Institute of Research Institutional Animal Care and Use Committee (IACUC). All procedures were performed in accordance to the Animal Welfare Act and in an animal facility approved by the Association for Assessment and Accreditation for Laboratory Animal Care International (AAALAC).
Yorkshire swine, weighing 25 to 35 kg (Animal Biotech Industry; Danboro, Pa), were refrained from food the night before the experiment but had free access to water. Surgical techniques and animal monitoring are described in a previous study by Arnaud et al. 19 Briefly, anesthesia was induced with intramuscular injection of ketamine HCl (30 mg/kg; Henry Schein, Inc, Melville, NY) and inhalation of isoflurane (3% to 4%). The animals were allowed to breathe spontaneously or through mechanical ventilation when necessary (Narkomed M ventilator, North American Dräger Telford, PA). An 18-to 20-gauge angiocatheter (Schein Care Corp, Irvine, Calif) was placed in the right Puncture model. The skin of the inguinal area of the right thigh was incised longitudinal to the groin approximately 12 cm to expose the femoral vasculature. The femoral artery was invasively isolated for approximately 4 cm on the distal side of the groin, free of fascia tissue. Lidocaine (Henry Schein, Inc) (1% to 2%) was spread on the artery to maximize dilation of the vessel. Any proximal side branches from the artery were ligated to avoid redirection of blood to the main circulation. After a brief period of stabilization and recording of baseline data, bulldog clamps were placed on the artery and a 4-mm hole was perforated by an aortic vascular punch (APU440, Medtronic, Minneapolis, Minn).
After this injury, the clamps were removed to produce uncontrolled hemorrhage (time 0 [T0]) resulting in immediate release of high-pressure arterial blood. Shed blood was removed by suction directed towards the blood accumulating in the groin cavity and not directly to the injured vessel area. Blood was aspirated into a vacuum bowl that was continuously weighed. The collected blood was recorded as pretreatment blood loss. Because of the high shear stress bleeding and shed blood accumulation, blood was still present in the wound cavity at the time of the dressing application (T1).
Treatment and monitoring. The animals were randomly assigned to one of the 11 bandage regimens (n ϭ 8 per group). Rectal temperature was monitored and maintained between 37°C and 39°C using a Bair Hugger device (Model 505, Bair Hugger, Minn). After uncontrolled bleeding for 45 seconds (T1), the treatment consisted of placement of the test dressing on the injured site with a SD placed over it. The test dressings were applied according to the manufacturer's directions for use.
A constant pressure of 175 Ϯ 28 mm Hg (measured by HM 28 pressure monitor, Dwyer, Calif) was manually applied over the wound with the dressings for 5 minutes. The pressure was then released and the skin apposed over the dressing, which resulted in a residual pressure of 30 Ϯ 5 mm Hg. At 15 minutes (T15), resuscitation was initiated by intravenous administration of 500 mL of isotonic colloid (Hextend, Biotime, Abbott, Abbott Park, Ill) through the external jugular vein over 30 minutes until T45 using a pump set (Masterflex, Cole Parmer, Vernon Hills, Ill). No additional fluid was administered regardless of the mean arterial pressure (MAP) or the blood loss.
The dressings remained in place on the wound, untouched for the remainder of the experiment. All animals were monitored until the end of the third hour (T180), at which time the dressings were removed, and the injured site was inspected for presence of clots. Animals that survived until T180 were euthanized with Euthasol solution (0.3 mL/ kg; Virbac AH, Inc, Fort Worth, Tex).
Recording and data acquisition. Shed blood volume was collected in a sealed container (2 L MediVac; CardinalHealth, Dublin, Ohio) and continuously weighed on a top-loading scale (PS 5100, Mettler-Toledo Inc, Columbus, Ohio). Rectal and wound temperature at the interface of wound blood and dressing were continuously recorded using temperature probes (BAT 12, Physitemp, Clifton, NJ). Blood pressure (MAP) and heart rate were continuously measured on a blood pressure analyzer (BPA; Micro-Med Inc, Louisville, Ky). Data were organized in an Excel spreadsheet (Microsoft Corp, Redmond, Wash) for further analysis. Arterial and mixed venous samples were taken at T0, T5, T15, T45, T60, T120, and T180. Blood samples were analyzed for complete blood count (Pentra 60Cϩ, HoribaABX, Irvine, Calif), thromboelastography (TEG; TEG5000, Haemoscope, Niles, Ill), coagulation parameters (Sta Compact, Diagnostica Stago, Parsippany, NJ), and blood gas using the ABL 750 analyzer (Radiometer, Copenhagen, Denmark).
Blood loss was divided into pretreatment (initial injury hemorrhage to 45 seconds) and post-treatment (from T1 to end point). Aspirated shed blood was continuously recorded and total post-treatment blood loss was calculated as measured shed blood, blood absorbed in test dressing, and blood absorbed in the SD, each weighed at the end of the experiment.
Recurrence of bleeding (rebleeding) was recorded to assess each product for bleeding control after release of the 5-minute manual compression or when MAP reached 40 mm Hg, or both. Recurrence of bleeding was accounted by incidence of aspiration (ie, no bleeding or bleeding retained in the dressing vs blood oozing from the dressings and able to be aspirated). Given this rebleeding definition, dressing effectiveness was analyzed in terms of percentage of animals that (1) exhibited one occurrence of rebleeding between the application of dressing and end of experiment, (2) exhibited more than one occurrence of rebleeding, and (3) that died before the second rebleeding event.
Statistical analysis. The design of the study was to evaluate each dressing on eight animals, unless there was a survival rate of Յ50% after testing the first four animals in a treatment group. In that case, group size was limited to four animals. This criterion of 50% survival was also applied after testing six animals. Analysis of variance, Mann-Whitney, Kruskal-Wallis, Fisher exact, and 2 tests were performed (Statistix, Tallahassee, Fla; SAS Institute Inc, Cary, NC). Data are presented as mean Ϯ standard deviation, and P Ͻ .05 was considered significant. The dressings were initially ranked according to survival because survival time of the animals across the 3-hour experiment directly affected quantitative blood loss levels; and secondarily, according to bleeding arrest, which was determined by quantitative assessment of aspirated blood.
RESULTS
The study used 69 of the 88 originally intended animals (n ϭ 8 animals per group). Three pigs died before T10 of excessive initial bleeding and were excluded from analyses. The final analysis included 66 animals. Dressings IC, HC, CHI, FP-21, and BLS were tested on four animals, and AB was tested on six because these dressings showed repeated failure. Overall, 35 of 66 pigs survived to T180, the experimental end point.
There was no difference between groups for the baseline parameters listed in Table II . These parameters were representative of physiologic and hematologic values for Yorkshire swine in our laboratory. All animals showed comparable hematology and hemostasis baseline measurements: hematocrit, 25.5% Ϯ 1.0%; hemoglobin, 8.6% Ϯ 0.3 g/dL; platelet count, 326 Ϯ 55 ϫ 10 6 /mL; prothrombin time, 14.0 Ϯ 0.3 seconds; fibrinogen, 138 Ϯ 21 mg/dL; reaction time (TEG-R), 593 Ϯ 138 seconds; kinetics (TEG-K), 171 Ϯ 56 seconds; maximum amplitude (TEG-MA), 75.7 Ϯ 2.2 mm; pH, 7.42 Ϯ 0.03; lactate, 0.95 Ϯ 0.11mM; and glucose, 3.4 Ϯ 0.6mM. Hemodynamic parameters after injury but before treatment (T45 seconds) were also comparable between groups (Table II) . Owing to blood loss of 18.8% Ϯ 5.2% EBV, MAP was reduced from an average baseline of 64.0 Ϯ 11.4 to 32.3 Ϯ 7.9 mm Hg across groups. The rate of initial rate bleeding (462 Ϯ 128 mL/min) was also comparable in all groups.
Survival. When ranked by the survival rate to the T180 end point, all dressings were superior to SD (Fig 1) . We used ACSϩ as a benchmark for comparison because it was deployed for combat when these experiments were conducted. Compared with 13% for animals treated with SD, survival rates of animals treated with WS, CEL, XS, and ACSϩ were 78% Ϯ 12%, which was significant (Fisher exact test, P Ͻ .001), and they also significantly outperformed FP-21, HC, CHI, and BLS, which exhibited the lowest survival rates (25% Ϯ 0%, P Ͻ .01). AB and IC dressings had an intermediate rate of survival (50%) and were not statistically different than the dressings showing the survival rate equivalent to ACSϩ or better. There was a gradation in survival time that paralleled the survival rates. The time of survival for treatment with the four top dressings averaged 160 Ϯ 13 minutes, whereas the bottom four dressings averaged 114 Ϯ 75 minutes ( 2 test, P Ͻ .01). Restoration of blood pressure. The highest blood pressure observed within each group reached levels Ͼ30 mm Hg after injury and dressing application. MAP Ͼ40 mm Hg after application of WS, CEL, XS, ACSϩ, HC, IC, AB, and CHI; whereas, FP-21, BLS, and SD were unable to restore and maintain blood pressures Ͼ40 mm Hg (Fig 2) .
Incidence of rebleeding (attainment of hemostasis). After dressing application (post-treatment) and compression release, but before fluid resuscitation, blood loss varied among groups. At least some bleeding was observed after application with each of the dressings. This bleeding was typically observed at compression release and upon MAP increase (Fig 3 and Table III ). However, group differences were documented between dressings in the control of bleeding. Bleeding (ie, incidence of aspirated blood) upon the release of manual compression ranged 50% to 62.5% for XS, WS, CEL, and ACSϩ, and 75% to 100% for all other dressings. This post-treatment bleeding, with a median 14.1% EBV (range, 5%-43% EBV), decreased MAP in all groups even further than occurred after injury (Table III) . Upon compensation, while MAP was restored, the same top four dressings exhibited less incidence of rebleeding. These four dressings, as well as CHI, resulted in no more than a 50% incidence of a second bleeding upon restoration of MAP. The other dressings were less effective, with an incidence of rebleeding upon MAP increase of 66.7% to 100% and the additional blood loss was 3% to 32% EBV. Overall, WS and CEL exhibited the lowest incidence of rebleeding.
Post-treatment blood loss. Blood loss was divided between blood absorbed in both the test and SDs and the blood aspirated from the wound (Fig 4) . Post-treatment blood loss, as quantified by both absorbed and aspirated amounts, is a direct indication of the capacity of the dressing to arrest hemorrhage. Dressings promoting higher survival rates showed better bleeding control with less blood aspirated or absorbed into the dressings. With ranking based solely on aspirated blood, the top dressings were WS, CEL, IC, ACSϩ, and XS. This order shows consistency with survival ranking, with the exception of IC. In parallel with analysis of the survival rate between the top four dressings and the bottom four dressings, analysis on aspirated blood yielded the same result (Mann-Whitney test, P Ͻ .001). Blood retained in the hemostatic dressings is illustrated in the black boxes in Fig 4. This suggests that WS, CEL, IC, and SD dressings had the highest absorbing capacity, whereas CHI, HC, and BLS had the lowest absorbing capacity. Additional characteristics of test hemostatic dressings. Additional observations made during the experiments regarding each dressing are illustrated in Appendix (online only). In addition to survival and hemostasis, the dressings were also evaluated for their ease of application and removal. This was subjectively assessed on a scale: easy, intermediate, or difficult. The difficulty in removing loose granular products was demonstrated by the high number of individual particles left behind, whereas the ease of removing fabric and solid dressings provided a clean wound ready for repair.
DISCUSSION
We tested 10 new hemostatic dressings in a 4-mm femoral arterial puncture swine model. This model was initially developed at the Institute of Surgical Research (ISR), San Antonio, Texas, using a 6-mm punch injury as described by Kheirabadi et al. 11, 20, 22 These two models, 4-and 6-mm puncture, showed similar levels of severity, causing 100% or 87% death, respectively, in swine treated with standard of care (ie, compressed gauze), with an initial rate of free bleeding blood loss of 462 mL/min in the 4-mm puncture vs 850 mL/min in the 6-mm puncture. With the ISR model, the animal was splenectomized and fluid resuscitation occurred at 30 seconds after the dressing was applied. Additional crystalloid was also provided to re-establish normotension. In our model, restoration of blood pressure is the effect of the dressing and natural physiologic compensation after one 500-mL bolus infusion at 15 minutes without additional fluid.
In our model, MAP decreased immediately after the arterial puncture injury during active bleeding (on average a 19% EBV blood loss caused MAP to drop to 32 mm Hg). MAP decreased further in dressings that did not prevent rebleeding at release of compression and was observed in approximately 50% of the experiments for each of the dressings. This blood loss, in addition to blood lost after resuscitation, brought the total post-treatment blood loss to Ͻ30% EBV for WS, CEL, XP, and IC, and to Ͼ50% EBV for AB, HC, FP-21, and BLS.
Survival rate was not significantly different among individual treatment groups, but survival rates and times for the top performing dressings as a group (WS, XS, CEL and ACSϩ) were significantly higher compared with the group of less effective dressings in this model (CHI, FP-21, HC, BLS). This relationship was consistent for post-treatment blood loss and incidence of rebleeding. Most of the dressings exhibited rebleeding during the release of compression or an increase in MAP, or both. Overall, WS, XS, CEL, and ACSϩ-the best performing dressings in this model as determined by survival-had lower incidences of blood loss at both of these times.
All other dressings, which were better than the SD, were less effective in terms of bleeding control, particularly during the secondary incidence of rebleeding. Most of the SD-treated animals died within about 60 minutes due to the high incidence of rebleeding and poor hemostasis. This indicates that in high shear-rate bleeding, absorption alone is not sufficient to inhibit rebleeding and promote survival. However, fabric-like dressings that are absorbent and also have additional hemostatic properties (ie, XS) provided better bleeding control by promoting early blood clotting and stopping blood from oozing into the dressings, hence increasing survival. The incidence of rebleeding after compression is released (first possible incidence) was high in the less effective dressings and was often fatal. It is compelling that the top performing dressings that controlled bleeding in this model corresponded to the same dressings previously observed as superior in the transection model. 19 These dressings, despite being consistently effective in comparison of multiple dressings, did yield more blood loss and less survival in the puncture model than in the transection model. This observation substantiates the severity of the hemorrhagic injury in this model despite there being no soft tissue injury, as is the case in the transection model.
Treatment with IC and AB dressings resulted in intermediate levels of survival (50%). Additional animals were allowed in the AB group because the initial performance was positive (3 of 4 survived). However, massive bleeding occurred with both of these dressings due to insufficient clotting. As blood filled the wound cavity, AB seemed unable to promote rapid clotting. Also, the IC membrane did not seem to allow ready absorption, which resulted in significant blood loss around the dressing edges in failed cases. Of the four other dressings, which yielded 25% survival, CHI, FP-21, and HC exhibited little initial absorption, followed by a high incidence of rebleeding. BLS, owing to the small size of the dressing unit, was unable to contain massive bleeding.
These findings suggest that with high shear bleeding, success is significantly influenced by the capacity of the dressing to both rapidly absorb blood and promote clotting. In terms of blood loss, survival is a confounding factor; animals that survived for a longer time had more occasions to experience rebleeding with increased MAP. The lack of rebleeding was an indication of dressing efficacy. On the other hand, animals that bled excessively after 15 minutes tended to die more rapidly, thereby exhibiting a lower total blood loss.
The 5-minute compression stage is necessary to promote close contact between the dressing and the source of bleeding. This compression procedure seems key for efficacy, initiating contact and adherence soon after application; otherwise, risk of rebleeding may be high, especially for dressings that depend on adherence (eg, HC and FP-21). It is obvious that in this puncture injury model, where the vessel is not fully sectioned and always under risk of high shear-rate bleeding, full obstruction of the created orifice by natural clot formation is almost unattainable. Thus, the initial closing of the aperture relies almost solely on the firm contact between dressing and blood vessel. This might explain why, when there is not a firm contact, rebleeding occurred at the release of compression. Granular or powder dressings are able to create a more complete seal and control bleeding better when MAP increases because they closely surrounded the vessel. In the firm-dressing category, flexible fabric-like dressings may offer a better first contact with the vessels (XS performed better than FP-21). In some cases, it seemed that a firm seal, when established for any dressing, created a pool of blood trapped in the wound underneath the dressing, which might eventually clot and act as a vascular plug.
Dressings that did not perform well in this model were still found to have interesting properties. At least one animal survived in each of the groups, suggesting that each of these test dressings may work in particular conditions. The dressings were tested as instructed by the manufacturer, but other factors could have contributed to their relatively less effective performance; their unit size could have been too small (BLS, FP-21), or the shape did not conform the wound (ie, IC, FP-21). The shape and rigidity of IC, for instance, was either extremely beneficial or extremely detrimental to its performance. The covering membrane did not easily dissolve and prevented rapid contact and absorption of blood with the hemostatic powder. In the few cases when the membrane did dissolve or break, the powder was effective in absorbing blood.
Dressings with strong adhesive properties (HC, CHI) were able to control bleeding extremely well when a strong seal was formed around the wound. A broken seal, however, became the source of leakage, leading to increased blood loss. We also observed that some granular materials were only partially soaked due to groin anatomy, placement of the dressing, or direction of bleeding. This posed problems during the removal stage, particularly for the powders (IC, CEL and WS). Removal by scooping the unabsorbed powder left a tremendous amount of residue in the wound that could be removed only with a high volume of rinse solution.
A major difference between the puncture injury model used in this study and the transection injury model used in previous protocols is that immediately after injury, the initial blood loss is lower and MAP remains high. This increases the chance to disrupt hemostasis in the puncture model and subsequently causes more blood loss and tends to lead to early death. Survival rate in the transection model was higher, despite an initially higher blood loss, likely because the animals were hypotensive at the time the hemostatic dress was applied. They also benefited from vessel retraction that occurred with this injury. Overall, the arterial puncture model is different yet relevant and very appropriate for bandage testing of severe hemorrhage observed in combat casualties.
CONCLUSIONS
WS, CEL, and XP performed similarly to ACSϩ in controlling bleeding. The dressings have a comparably low incidence of rebleeding, and if rebleeding occurs, they limit blood loss and allow restoration of MAP Ͼ50 mm Hg, which ultimately leads to survival. Alternately, CHI, FP-21, HC, and BLS did not perform as well in this model of a puncture injury with high-pressure bleeding. These dressings exhibited a high incidence of rebleeding, leading to a high volume of blood loss and a MAP Ͻ40 mm Hg, which did not support survival for the 3-hour experimental period.
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